> News
 > MaaT Pharma Receives U.S. FDA Response
News
03/02/2023

MaaT Pharma Receives U.S. FDA Response

Outlining Path Forward for Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease and Reports Cash and Revenues for Fourth Quarter 2022.

Access the press release

 

Our news

News
24/08/2023
Alliance Promotion Microbiote applauds the new legislation securing stool collection in France
> READ
News
11/01/2023
Organic S. boulardii: A Probiotic Breakthrough by Lallemand
> READ
News
08/11/2024
EMIH is a partner of the 8th edition of the Microbiota and Health Day organized by Lyonbiopôle Auvergne-Rhône-Alpes.
> READ
> See all news